Healthcare paid-media planning questions
Status: qualitative, unscored planning aid; not medical, privacy, or legal advice.
Required gates
- Context gate: identify the provider, service or product, audience, jurisdiction, care setting, objective, conversion, accountable privacy owner, and clinical reviewer.
- Evidence gate: verify current official source IDs from platforms and regulators, including
hhs-tracking-guidance-officialwhen its scope is applicable. - Privacy gate: determine whether pages, events, URLs, forms, audiences, or vendor flows could disclose protected or sensitive health information; block uncertain tracking uses.
- Clinical-claim gate: require approved indication, evidence, limitations, risk language, and qualified review before using outcome or comparative claims.
- Regulatory gate: identify category, region, certification, targeting, disclosure, accessibility, and emergency-content requirements from current official evidence.
- Capability gate: keep sensitive data out of unsupported providers, prompts, reports, logs, and account operations.
Planning questions
- What service or product is offered, to whom, by which authorized entity?
- Which claims are approved, understandable, balanced, and supported?
- Which conversion events are useful without exposing health status or treatment interest?
- Which targeting or creative concepts risk sensitive-trait inference or exploitation?
- How will consent, vendor access, retention, deletion, incident response, and review work?
- What should happen when a user may need urgent or professional care rather than an ad?
Candidate considerations
- Consider education, access, service explanation, and trust hypotheses only after the privacy, clinical, regulatory, and platform gates pass.
- Separate marketing measurement from medical outcomes and never infer diagnosis.
Output guardrails
- Return questions, source IDs, approvals, unresolved risks, owners, and stop conditions.
- Do not prescribe eligibility, targeting, tracking, claims, bids, allocations, or outcomes.